{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:43:08Z","timestamp":1769632988444,"version":"3.49.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>The recent approval of raltegravir granules for suspension in the newborn population offers a new option for the antiretroviral prophylaxis of newborns for the prevention of perinatal transmission. However, there are little data on its use in preterm infants, nor on outcomes following its use as empiric HIV therapy for newborns subsequently found to be infected. We describe here the use of RAL granules for suspension in these cases.<\/jats:p>","DOI":"10.1097\/inf.0000000000002180","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T23:52:35Z","timestamp":1535586755000},"page":"410-412","source":"Crossref","is-referenced-by-count":3,"title":["Use of Triple Combination Antiretroviral Therapy With Raltegravir as Empiric HIV Therapy in the High-risk HIV-exposed Newborn"],"prefix":"10.1097","volume":"38","author":[{"given":"Marie-Julie","family":"Trahan","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Lamarre","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Montr\u00e9al, Department of Pediatrics, Montreal, Quebec, Canada"},{"name":"CHU Sainte-Justine, Division of Infectious Diseases, Montreal, Quebec, Canada"},{"name":"CHU Sainte-Justine Research Center, Centre Maternel et Infantile sur le SIDA, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Elaine","family":"Metras","sequence":"additional","affiliation":[{"name":"CHU Sainte Justine, Department of Pharmacy, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Kakkar","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Montr\u00e9al, Department of Pediatrics, Montreal, Quebec, Canada"},{"name":"CHU Sainte-Justine, Division of Infectious Diseases, Montreal, Quebec, Canada"},{"name":"CHU Sainte-Justine Research Center, Centre Maternel et Infantile sur le SIDA, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"301763","DOI":"10.1155\/2013\/301763","article-title":"Comparison of pregnancies between perinatally and sexually HIV-infected women: an observational study at an urban hospital.","volume":"2013","author":"Badell","year":"2013","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R2-20230912","first-page":"51","article-title":"Impact of HIV-1 infection and pregnancy on maternal health: comparison between perinatally and behaviorally infected young women.","volume":"4","author":"Munjal","year":"2013","journal-title":"Adolesc Health Med Ther"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/ijerph13060568","article-title":"Viral suppression and resistance in a cohort of perinatally-HIV infected (PHIV+) pregnant women.","volume":"13","author":"Cruz","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jpids\/pis106","article-title":"The young and the resistant: HIV-infected adolescents at the time of transfer to adult care.","volume":"2","author":"Van der Linden","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3851\/IMP3139","article-title":"Therapeutic drug monitoring guided raltegravir dosing for prevention of vertical transmission in a premature neonate born to a woman living with perinatally acquired HIV.","volume":"22","author":"Kreutzwiser","year":"2017","journal-title":"Antivir Ther"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/cid\/ciu432","article-title":"Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral blood.","volume":"59","author":"Bitnun","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/COH.0000000000000127","article-title":"Very early combination antiretroviral therapy in infants: prospects for cure.","volume":"10","author":"Rainwater-Lovett","year":"2015","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201904000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:32:53Z","timestamp":1694557973000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201904000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002180","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}